Catalyst Wire Dossier Catalyst Wire Dossier

M5717

M5717 · Merck KGaA
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for M5717, covering 2024-05-01 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2) [Phase 2]

See pricing